Back to homepage


Clinical potential of treatment with semaglutide in type 2 diabetes patients

Authors: Michael E Røder

This review discusses the efficacy and safety of semaglutide, which have
been investigated in an extensive clinical development
program including more than 9,000 patients with type 2


Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options

Authors: Rudolf Hoermann, John E M Midgley, Rolf Larisch, Johannes W Dietrich

This review discusses levothyroxine therapy in the alleviation of hypothyroidism, focusing on complex needs, the available options and setpoints.


New uses and formulations of glucagon for hypoglycaemia

Authors: Pilar I Beato-Víbora PhD, Francisco J Arroyo-Díez PhD

Hypoglycaemia is a frequent complication of insulin
therapy. Injectable glucagon and oral intake of carbohydrates are
the recommended treatments for severe and non-severe
hypoglycaemic episodes, respectively. New uses and formulations of glucagon are reviewed and discussed in this article.


Menopause hormone therapy: latest developments and clinical practice

Authors: Tomas Fait MD, PhD

Menopause hormone therapy still remains a dominant
therapeutic modality in climacteric medicine. The core medical
skill is the ability to choose the optimal MHT preparation for
the given patient. Such choice is based on an understanding of
various clinical and metabolic effects of MHT depending on the
composition, dosage, and the method of application, this article discusses those choices.


The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy

Authors: Yue Zhao MD, Rishi P Singh MD

This review discusses recent clinical trials and guidelines for anti-VEGF use in proliferative diabetic retinopathy.